ReviewDiagnostics (Basel, Switzerland)2025
Eosinophilic Esophagitis: A Review of Histopathological and Diagnostic Aspects.
Review in Diagnostics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Clinical Patterns and Outcomes of Eosinophilic Esophagitis in Children and Adolescents at a Tertiary Care Center in Lebanon.Children (Basel, Switzerland) · 2026Article
- The Immune Architecture of Eosinophilic Esophagitis: Mechanisms, Therapeutic Targets, and Precision Management.ImmunoTargets and therapy · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Eosinophilic esophagitis (EoE) has emerged as a distinct clinicopathological entity and a major cause of upper gastrointestinal morbidity worldwide. Once misinterpreted as a variant of Gastroesophageal Reflux Disease (GERD), its unique identity as an immune-mediated inflammatory disease was solidified by foundational studies in the early 1990s. This discursive review synthesizes key findings from peer-reviewed literature to outline the evolution of EoE's diagnosis and management. The review highlights that a definitive diagnosis is now a multidisciplinary process that integrates clinical symptoms, characteristic endoscopic findings, and, most critically, a comprehensive histopathological evaluation of esophageal biopsies. It emphasizes the limitations of relying on a single eosinophil count and underscores the value of ancillary histological features and the Histologic Scoring System, which provides a more nuanced and predictive assessment of disease activity. The review also discusses the evolving understanding of PPI-responsive esophageal eosinophilia as a subtype of EoE, streamlining the diagnostic approach. In conclusion, while EoE is a chronic condition that can lead to significant esophageal remodeling if untreated, a robust diagnostic framework and a range of effective therapies are now available to manage the disease, though a continued lack of clinical awareness remains a key challenge.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.